 "Indian destocking hits GSK consumer health care business")
Shares of pharmaceutical companies were trading under pressure with the frontline stocks like Sun Pharmaceutical Industries, Lupin and Dr Reddy’s Laboratories hitting their respective 52-week lows in early morning deals.
At 10:23 am; Nifty Pharma index, the largest loser among sectoral indices, was down 1.5% as compared to a marginal 0.02% decline in the Nifty 50 index. In past three trading sessions, the pharma index slipped 3.3% as against 1% fall in the benchmark index.
Among the individual stocks, Biocon has slipped 8% to Rs 347 after the US Food and Drug Administration (FDA) issued Form 483 with
At 10:23 am; Nifty Pharma index, the largest loser among sectoral indices, was down 1.5% as compared to a marginal 0.02% decline in the Nifty 50 index. In past three trading sessions, the pharma index slipped 3.3% as against 1% fall in the benchmark index.
Among the individual stocks, Biocon has slipped 8% to Rs 347 after the US Food and Drug Administration (FDA) issued Form 483 with
